Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review.

Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review.

HIV infection is associated with an increased risk of cardiovascular disease (CVD). Chronic low-grade immune activation is likely one of the driving mechanisms. This systematic review provides an overview of the evidence addressing the relation between immune markers and surrogate markers of CVD (ex...

Full description

Bibliographic Details
Main Authors:	Alinda G Vos, Annelieke Hulzebosch, Diederick E Grobbee, Roos E Barth, Kerstin Klipstein-Grobusch
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5234789?pdf=render

Similar Items

Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review.
by: Alinda G Vos, et al.
Published: (2016-01-01)

Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk
by: Alinda G. Vos, et al.
Published: (2021-07-01)

Unexpected low frequency of respiratory symptoms in an HIV-positive urban sub-Saharan population compared to an HIV-negative control group
by: Maren Kummerow, et al.
Published: (2019-09-01)

Erratum: Unexpected low frequency of respiratory symptoms in an HIV-positive urban sub-Saharan population compared to an HIV-negative control group
by: Maren Kummerow, et al.
Published: (2021-04-01)

Understanding of and perceptions towards cardiovascular diseases and their risk factors: a qualitative study among residents of urban informal settings in Nairobi
by: Diederick E Grobbee, et al.
Published: (2019-06-01)

Cardiovascular disease risk in an urban African population: a cross-sectional analysis on the role of HIV and antiretroviral treatment
by: Alinda G. Vos, et al.
Published: (2019-12-01)

Electrocardiographic and echocardiographic abnormalities in urban African people living with HIV in South Africa.
by: Geert V T Roozen, et al.
Published: (2021-01-01)

Heart Rate Variability, HIV and the Risk of Cardiovascular Diseases in Rural South Africa
by: Noortje G. Godijk, et al.
Published: (2020-02-01)

The association between HIV infection and pulmonary function in a rural African population.
by: Meri R J Varkila, et al.
Published: (2019-01-01)

The Utility of the Lipoprotein-Associated Phospholipase A (Lp-PLA) Assay in Detecting Abnormalities in Lipid Metabolism and Cardiovascular Risk in an HIV-Infected South African Cohort
by: Elizabeth S. Mayne MD, et al.
Published: (2019-10-01)

Predictors of impaired pulmonary function in people living with HIV in an urban African setting
by: Sarah E. van Riel, et al.
Published: (2021-08-01)

Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir
by: Alinda G. Vos, et al.
Published: (2018-12-01)

Determinants of Mortality from Cardiovascular Disease in the Slums of Nairobi, Kenya
by: Frederick M. Wekesah, et al.
Published: (2020-04-01)

The Role of Immune Correlates and Surrogate Markers in the Development of Vaccines and Immunotherapies for Plague
by: E. D. Williamson
Published: (2012-01-01)

A Global Analysis of Associations between Fine Particle Air Pollution and Cardiovascular Risk Factors: Feasibility Study on Data Linkage
by: Min Zhao, et al.
Published: (2020-08-01)

Prevalence of cardiovascular medication on secondary prevention after myocardial infarction in China between 1995-2015: A systematic review and meta-analysis.
by: Min Zhao, et al.
Published: (2017-01-01)

Safety and Immunogenicity of Measles Vaccination in HIV-Infected and HIV-Exposed Uninfected Children: A Systematic Review and Meta-AnalysisResearch in Context
by: Eleonora A.M.L. Mutsaerts, et al.
Published: (2018-07-01)

Surrogate markers in clinical trials
by: Lewis, Nigel da Costa
Published: (2002)

Changes in Peripheral Lipoatrophy, Surrogate Markers of Cardiovascular Disease, and Mitochondria after Rosiglitazone in HIV-infected individuals with Lipoatrophy
by: Tungsiripat, Marisa
Published: (2011)

The Effect of Argan Oil on Surrogate Markers in Cardiovascular Diseases: A Systematic Review and Meta-Analysis
by: Maryam Ghaseminasab Parizi, et al.
Published: (2020-12-01)

Hypertension in a rural community in South Africa: what they know, what they think they know and what they recommend
by: Vita W. Jongen, et al.
Published: (2019-03-01)

Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes
by: Latika Sibal, et al.
Published: (2011-01-01)

Elastosis in Breast Cancer as a Surrogate Marker for Estrogen Receptor Positivity
by: Samah Al Abri, et al.
Published: (2021-03-01)

Atherosclerosis Surrogate Marker in Diabetic Patients
by: Seid Kazem Razavi Ratki, et al.
Published: (2016-03-01)

Surrogate markers to determine drug activity
by: McClelland, Carol Margaret
Published: (2004)

Hibernating myocardium : prevalence and surrogate markers
by: Al-Mohammad, Abdallah
Published: (2017)

Comparative performance of pooled cohort equations and Framingham risk scores in cardiovascular disease risk classification in a slum setting in Nairobi Kenya
by: Frederick M. Wekesah, et al.
Published: (2020-06-01)

Cardiovascular Calcification as a Marker of Increased Cardiovascular Risk and a Surrogate for Subclinical Atherosclerosis: Role of Echocardiography
by: Andrea Faggiano, et al.
Published: (2021-04-01)

Mycobacterium tuberculosis co-infection is associated with increased surrogate marker of the HIV reservoir
by: Jingna Xun, et al.
Published: (2020-10-01)

Study on the functional role of immunoglobulin E as surrogate marker for HIV/AIDS infection
by: Sonaimuthu B, et al.
Published: (2012-09-01)

High HPgV replication is associated with improved surrogate markers of HIV progression.
by: Gibran Horemheb-Rubio, et al.
Published: (2017-01-01)

Cystatin B, cathepsin L and D related to surrogate markers for cardiovascular disease in children.
by: Magnus Dencker, et al.
Published: (2017-01-01)

Knowledge and awareness of and perception towards cardiovascular disease risk in sub-Saharan Africa: A systematic review.
by: Daniel Boateng, et al.
Published: (2017-01-01)

Identification of neutrophil activation markers as novel surrogate markers of CF lung disease.
by: Timo Rath, et al.
Published: (2014-01-01)

Surrogate markers in transitional cell carcinoma of bladder
by: McKnight, J. J.
Published: (2004)

Nocturnal non-dipping hypertension – A clinical surrogate marker of oxidative stress and cardiovascular adversity
by: C.K. Das, et al.
Published: (2014-11-01)

Imaging Dopaminergic Dysfunction as a Surrogate Marker of Neuropathology in a Small-Animal Model of HIV
by: Dianne E. Lee, et al.
Published: (2014-11-01)

Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes.
by: James C Needell, et al.
Published: (2017-01-01)

Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults.
by: Anita S Iyer, et al.
Published: (2016-01-01)

Surrogate atherosclerosis markers in patients with stage I-II arterial hypertension
by: E. A. Grigoricheva, et al.
Published: (2009-02-01)